All Posts:Medicare

• Despite Medicare Coverage, Many Cancer Patients Still Do Not Receive Testing That Guides Treatment Options

  While there has been a recent increase among Medicare recipients in genomic testing that helps match cancer patients to the most effective treatment for their tumor, many Medicare beneficiaries with cancer are still not receiving next-generation sequencing, according to a new analysis by Georgetown University researchers.

  Category: News Release Tags: genetic testing, Medicare

• Rise in Claim Denial Rates for Cancer-Related Advanced Genetic Testing

  A newly published analysis by Georgetown Lombardi member So-Yeon Kang, PhD, MBA, and colleagues has found that both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national coverage determination that established coverage standards for NGS testing. Read more about this research.

  Category: News Release Tags: cancer, genetic testing, health insurance, Medicare, next generation sequencing testing